Reeve J
Clin Orthop Relat Res. 1986 Dec(213):264-78.
Published normal histomorphometric data were used to derive distributions of thicknesses of trabecular plates and completed bone remodelling units (the basic multicellular unit carrying out bone remodelling, the BMU, when completed is termed a structural unit BSU). A stochastic model was set up to investigate the predictions of current BMU theory. Each of 100 trabecular "thicknesses" was drawn from the appropriate normal distribution using a pseudorandom number generator. Each day, each of its two surfaces when quiescent was assumed to have a 1:900 chance of initiating a remodelling cycle. Resorption (active, 12 days; reversal phase, 27 days) was followed by formation (94 +/- 35 days) and resulted in BMU balance when resorption depth was 36.8 +/- 9.2 micron. Fenestration (thickness less than 0) was assumed to lead to permanent loss of the trabecula. The original model unrealistically increased its mean trabecular thickness as thin trabeculae were lost. This was corrected by assuming that thin trabeculae had greater osteoblastic stimulation and a consequent tendency to thicken, perhaps due to higher mechanical loading. Over 20 years, 14% of trabeculae were lost when the BMU balance was exact and the distribution of trabecular thicknesses was unchanged. About one-half of fenestrations were due to deeper-than-average resorption cavities developing in thin trabeculae, and the remainder to coincident remodelling on both surfaces. A 10% fall in osteoblast lifespan resulted in an additional 36.7% loss of trabecular bone volume and mean trabecular thickness fell to 83.1 micron, compatible with Courpron's data. Simulating more rapid mechanisms of bone loss, approximately 50% of trabeculae could be lost after ten years by the arrest of bone formation; the doubling of resorption depth with unchanged bone formation; and a doubling in the rate of initiation of new BMUs with unchanged bone formation rate, all three followed by complete recovery of BMU balance after only two years. In each case, mean trabecular thickness fell only transiently but trabeculae continued to be lost after recovery. Prolonged osteoblast life span was the most likely explanation for the increased mean trabecular thicknesses and trabecular bone volumes seen in patients with osteoporosis, when treated with sodium fluoride plus calcium supplements or daily injections of parathyroid peptide hPTH 1-34.
已发表的正常组织形态计量学数据被用于推导骨小梁板厚度和完整骨重塑单元(进行骨重塑的基本多细胞单元,即BMU,完成后称为结构单元BSU)的分布。建立了一个随机模型来研究当前BMU理论的预测。使用伪随机数生成器从适当的正态分布中抽取100个骨小梁“厚度”中的每一个。每天,假设其两个静止表面中的每一个都有1:900的机会启动一个重塑周期。吸收(活跃期12天;逆转期27天)之后是形成期(94±35天),当吸收深度为36.8±9.2微米时达到BMU平衡。穿孔(厚度小于0)被认为会导致骨小梁的永久性丢失。原始模型在薄骨小梁丢失时不切实际地增加了其平均骨小梁厚度。通过假设薄骨小梁具有更大的成骨细胞刺激作用以及随之而来的增厚趋势(可能是由于更高的机械负荷)对其进行了修正。在20年的时间里,当BMU平衡精确且骨小梁厚度分布不变时,14%的骨小梁会丢失。大约一半的穿孔是由于薄骨小梁中形成了比平均深度更深的吸收腔,其余的是由于两个表面同时发生重塑。成骨细胞寿命下降10%会导致骨小梁骨体积额外损失36.7%,平均骨小梁厚度降至83.1微米,这与库尔普龙的数据相符。模拟更快的骨质流失机制,通过停止骨形成,十年后大约50%的骨小梁可能会丢失;在骨形成不变的情况下吸收深度加倍;在骨形成速率不变的情况下新BMU启动速率加倍,所有这三种情况在仅仅两年后BMU平衡都会完全恢复。在每种情况下,平均骨小梁厚度仅短暂下降,但恢复后骨小梁仍会继续丢失。当用氟化钠加钙补充剂或每日注射甲状旁腺肽hPTH 1-34治疗骨质疏松症患者时,成骨细胞寿命延长最有可能解释所观察到的平均骨小梁厚度和骨小梁骨体积增加的现象。